Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: The case experience with preclinical mechanistic and early clinical–translational studies
- 1 November 2007
- journal article
- review article
- Published by Elsevier BV in Toxicology and Applied Pharmacology
- Vol. 224 (3), 290-299
- https://doi.org/10.1016/j.taap.2007.01.025
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006
- Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factorsNature Chemical Biology, 2005
- Photodynamic therapy in dermatology – an updatePhotodermatology, Photoimmunology & Photomedicine, 2005
- Role of mitochondrial cardiolipin peroxidation in apoptotic photokilling of 5-aminolevulinate-treated tumor cellsArchives of Biochemistry and Biophysics, 2005
- Bax is essential for mitochondrion-mediated apoptosis but not for cell death caused by photodynamic therapyBritish Journal of Cancer, 2003
- Domain-dependent Photodamage to Bcl-2Online Journal of Public Health Informatics, 2003
- Systemic Photodynamic Therapy with Aminolevulinic Acid Induces Apoptosis in Lesional T Lymphocytes of Psoriatic PlaquesJournal of Investigative Dermatology, 2002
- Promotion of photodynamic therapy-induced apoptosis by stress kinasesCell Death & Differentiation, 1999
- Protease activation and cleavage of poly(ADP-ribose) polymerase: an integral part of apoptosis in response to photodynamic treatment.1998
- Clonal evolution of t(14;18) follicular lymphomas demonstrated by immunoglobulin genes and the 18q21 major breakpoint region.1987